In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


12-year positive survival data for BSD's hyperthermia therapy:

This article was originally published in Clinica

Executive Summary

A 12-year follow-up study has shown positive survival rates for BSD Medical's precision-focused hyperthermia therapy device, BSD-2000, when used as an enhancement to radiotherapy. The 358-patient study assessed patients with locally-advanced pelvic tumours, and many had extremely poor prognoses. The follow-up found that patients who received radiation plus hyperthermia therapy had a survival rate of 37%, compared with 20% for those receiving radiation alone. Furthermore, the margin of increased survival rate of patients was similar at 12 years (an 85% increase) as at 3 years (an 89% increase). One of the primary concerns about new therapies is their durability, said Salt Lake City, Utah-based BSD. The findings were presented at the European Society for Hyperthermic Oncology, in Prague, Czech Republic, in June.

You may also be interested in...

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.

Start-Up Spotlight: Iraq War Veteran Deploys ‘Bone Paint’ To Combat Traumatic Injuries

Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts